Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00641810 · ClinicalTrials.gov registry record · NA

The Effect of Caffeine Reduction on Snoring and Quality of Life

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT00641810: Completed NA study, sponsored by University of Vermont.

NCT00641810 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00641810, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Snoring is a problem for many people, often disturbing energy level, quality of sleep, and the relationship with a bed partner. Two observational studies that have indicated a relationship between the consumption of caffeine and snoring. The objective of this study will be to observe the degree of snoring and quality of sleep when caffeine intake is reduced over a period of four weeks. This will be a prospective, before-and-after study of a behavioral intervention. This study will engage thirty adults who report snoring, drink two cups of coffee or more per day (or an equivalent amount of caffeine), and have a consistent bed partner who can report on snoring severity. Both subject and partner will be asked to fill out a diary each day. The subjects will record the type of caffeine consumed, time at which each beverage was ingested, the total minutes of physical exercise, any caffeine withdrawal symptoms, quality of sleep, and energy in the morning. The partner (reporter) will rate his or her own sleep quality and energy in the morning, as well as the snoring level of the subject. Beginning the second week of the study, the subject will reduce caffeine intake to half the baseline consumption, and on the third week, will eliminate caffeine altogether. At the end of each week, the participants will be asked to mail their diaries in to the researchers and start a new series of entries. The study team will also call each week to answer any questions or concerns of the subject and reporter, and encourage continued reporting. When six weeks have elapsed following the completion of the last diary, the investigators will make a final call to the participants to record their current level of snoring, quality of sleep, and daily energy level.

Interventions

  • BEHAVIORAL Caffeine reduction

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-03
Est. Completion 2011-06
Phase NA
University of Vermont

162 total trials

What the finished NCT00641810 record still lists

NCT00641810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Caffeine reduction is the first listed.

NCT00641810 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00641810 about?

NCT00641810 is a clinical study titled "The Effect of Caffeine Reduction on Snoring and Quality of Life". Snoring is a problem for many people, often disturbing energy level, quality of sleep, and the relationship with a bed partner. Two observational studies that have indicated a relationship between the consumption of caffeine and snoring. The objective of this study will be to observe the degree of s...

What is the current status of trial NCT00641810?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-03. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00641810?

The interventions under investigation include: Caffeine reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT00641810?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00641810's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00641810, the US trial registry maintained by the National Library of Medicine. NCT00641810 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.